Mast will be showcasing its newest product offerings at the forthcoming European Congress of Clinical Microbiology and Infectious Diseases (ECCMID).
The event, which will be taking place in Amsterdam from April 9th to 12th, will give the company an opportunity to demonstrate its latest innovations to an expected 10,000 delegates.
“Mast will be attending this year's European Congress of Clinical Microbiology and Infectious Diseases in Amsterdam.“
Its antibiotic susceptibility tests will be the focus of its presentations, including antimicrobial resistance products in the Mastdisc range, with Mast representatives to be on hand to discuss their functionality and applications.
The Mastpharma range of services will also be showcased, demonstrating how they can be used for the evaluation of novel antimicrobial compounds for the pharmaceutical industry.
The company said: "Upon visiting the Mast stand, you will be given the opportunity to discuss the benefits of these products and learn how to implement them into the laboratory to simplify testing and improve workflow."
ECCMID is organised by the European Society of Clinical Microbiology and Infectious Diseases and consists of a series of keynote lectures, symposia, educational workshops and meet-the-expert sessions.See all the latest jobs in Science